Medytox Inc.'s Form 4 filing
Evolus, Inc. (EOLS) · filed Oct 18, 2023
- Accession no.
- 0001387131-23-012379
- Filed
- Oct 18, 2023
- Trade date
- Oct 16, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $12.7M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Medytox Inc.CIK 0001848514 | Other: Former 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2023 | Common Stock, $0.00001 par value per share | SSaleDisposed | −1,690,663 | $7.50 | −$12,679,972.5 | 3,381,326 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.